Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Short term Debt: 2021

Historic Short term Debt for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $5.3 million.

  • Cardiol Therapeutics' Short term Debt was N/A to $1.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2021, which is N/A change from last year.
  • Per Cardiol Therapeutics' latest filing, its Short term Debt stood at $5.3 million for FY2021.
  • In the past 5 years, Cardiol Therapeutics' Short term Debt ranged from a high of $5.3 million in FY2021 and a low of $5.3 million during FY2021.
  • Over the past 1 years, Cardiol Therapeutics' median Short term Debt value was $5.3 million (recorded in 2021), while the average stood at $5.3 million.